| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008564535 |
| P356 | DOI | 10.1186/2044-5040-3-17 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC3702458 |
| https://europepmc.org/articles/PMC3702458?pdf=render | ||
| https://skeletalmusclejournal.biomedcentral.com/counter/pdf/10.1186/2044-5040-3-17 | ||
| P932 | PMC publication ID | 3702458 |
| P698 | PubMed publication ID | 23815988 |
| P5875 | ResearchGate publication ID | 244479807 |
| P50 | author | Antoine Muchir | Q47352540 |
| P2093 | author name string | Wei Wu | |
| Young Jin Kim | |||
| Howard J. Worman | |||
| Jason C. Choi | |||
| Sarah A. Reilly | |||
| P2860 | cites work | Real-time PCR based on SYBR-Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions | Q21256663 |
| Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy | Q22009039 | ||
| Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins | Q24298586 | ||
| Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C | Q24310845 | ||
| Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy | Q24317622 | ||
| Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy | Q24320253 | ||
| Unusual type of benign x-linked muscular dystrophy | Q24519418 | ||
| Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle | Q24538577 | ||
| Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. | Q24539152 | ||
| Mouse model carrying H222P- Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies | Q60535383 | ||
| High Incidence of Sudden Death with Conduction System and Myocardial Disease Due to Lamins A and C Gene Mutation | Q63531545 | ||
| beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation | Q77452079 | ||
| Impact of sarcoglycan complex on mechanical signal transduction in murine skeletal muscle | Q81215523 | ||
| gamma-Sarcoglycan deficiency increases cell contractility, apoptosis and MAPK pathway activation but does not affect adhesion | Q81527124 | ||
| Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease | Q28139053 | ||
| Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B) | Q28144565 | ||
| Laminopathies and the long strange trip from basic cell biology to therapy | Q28251294 | ||
| The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein | Q28287914 | ||
| Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers | Q28593090 | ||
| Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy | Q30498939 | ||
| Cardiac Features of an Unusual X-Linked Humeroperoneal Neuromuscular Disease | Q33147218 | ||
| Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan. | Q34171616 | ||
| Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy | Q34580311 | ||
| Mitogen-Activated Protein Kinase Inhibitors Improve Heart Function and Prevent Fibrosis in Cardiomyopathy Caused by Mutation in Lamin A/C Gene | Q34700605 | ||
| Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A | Q34994784 | ||
| Role of TGF-β signaling in inherited and acquired myopathies | Q35166254 | ||
| LMNA cardiomyopathy: cell biology and genetics meet clinical medicine. | Q35232610 | ||
| Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. | Q35632054 | ||
| Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma | Q35949518 | ||
| Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? | Q35954331 | ||
| Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology | Q36360412 | ||
| Dual specificity phosphatase 4 mediates cardiomyopathy caused by lamin A/C (LMNA) gene mutation | Q36418867 | ||
| Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins. | Q37089986 | ||
| cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins | Q37397300 | ||
| The nuclear envelope as a signaling node in development and disease. | Q37634713 | ||
| Novel mitogen-activated protein kinase kinase inhibitors | Q37828536 | ||
| MEK inhibitors: a patent review 2008 – 2010 | Q37872791 | ||
| X-linked muscular dystrophy with early contractures and cardiomyopathy (Emery-Dreifuss type). | Q39684744 | ||
| Enhancements and modifications of primer design program Primer3. | Q40230955 | ||
| The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated | Q41711274 | ||
| Effects of storage temperature and time on clinical biochemical parameters from rat serum. | Q41815779 | ||
| Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene. | Q44187054 | ||
| Altered activity of signaling pathways in diaphragm and tibialis anterior muscle of dystrophic mice. | Q44915435 | ||
| Altered mitogen-activated protein kinase signaling in dystrophic (mdx) muscle | Q56770399 | ||
| Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene | Q57640076 | ||
| Limb-Girdle Muscular Dystrophy Due to Emerin Gene Mutations | Q58036326 | ||
| The nuclear lamina is a meshwork of intermediate-type filaments | Q59091782 | ||
| Lamin A/C Gene Mutation Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement | Q59461161 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Emery-Dreifuss muscular dystrophy | Q1335642 |
| P304 | page(s) | 17 | |
| P577 | publication date | 2013-07-01 | |
| P1433 | published in | Skeletal Muscle | Q27723741 |
| P1476 | title | Inhibition of extracellular signal-regulated kinase 1/2 signaling has beneficial effects on skeletal muscle in a mouse model of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutation | |
| P478 | volume | 3 |
| Q92757194 | Cellular and Animal Models of Striated Muscle Laminopathies |
| Q54976812 | Cofilin-1 phosphorylation catalyzed by ERK1/2 alters cardiac actin dynamics in dilated cardiomyopathy caused by lamin A/C gene mutation. |
| Q92727241 | Deficiency of emerin contributes differently to the pathogenesis of skeletal and cardiac muscles in LmnaH222P/H222P mutant mice |
| Q52580381 | Elevated dual specificity protein phosphatase 4 in cardiomyopathy caused by lamin A/C gene mutation is primarily ERK1/2-dependent and its depletion improves cardiac function and survival. |
| Q91997396 | Emery-Dreifuss muscular dystrophy |
| Q51290025 | FHL1B Interacts with Lamin A/C and Emerin at the Nuclear Lamina and is Misregulated in Emery-Dreifuss Muscular Dystrophy |
| Q35253089 | Gamma-sarcoglycan is required for the response of archvillin to mechanical stimulation in skeletal muscle |
| Q39181367 | Lamin A/C Cardiomyopathies: Current Understanding and Novel Treatment Strategies |
| Q50480636 | Lamina-associated polypeptide 1 is dispensable for embryonic myogenesis but required for postnatal skeletal muscle growth. |
| Q51239755 | Macrocyclic MEK1/2 inhibitor with efficacy in a mouse model of cardiomyopathy caused by lamin A/C gene mutation |
| Q35165138 | Muscle-derived extracellular signal-regulated kinases 1 and 2 are required for the maintenance of adult myofibers and their neuromuscular junctions |
| Q27004670 | Post-translational modifications of intermediate filament proteins: mechanisms and functions |
| Q92094415 | RNA Sequence Analyses throughout the Course of Mouse Cardiac Laminopathy Identify Differentially Expressed Genes for Cell Cycle Control and Mitochondrial Function |
| Q28552721 | Selumetinib, an Oral Anti-Neoplastic Drug, May Attenuate Cardiac Hypertrophy via Targeting the ERK Pathway |
| Q26741163 | Skeletal Muscle Laminopathies: A Review of Clinical and Molecular Features |
| Q27006719 | The nuclear envelope: an intriguing focal point for neurogenetic disease |
| Q98163745 | The ties that bind: functional clusters in limb-girdle muscular dystrophy |
Search more.